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Abstract 
Three novel glass compositions, identified as NCL2 (SiO2-based), NCL4 (B2O3-based) and 
NCL7 (SiO2-based), along with apatite-wollastonite (AW) were processed to form sintered 
dense pellets, and subsequently evaluated for their in vitro bioactive potential, resulting 
physico-chemical properties and degradation rate. Microstructural analysis showed the 
carbonated hydroxyapatite (HCA) precipitate morphology following SBF testing to be 
composition-dependent. AW and the NCL7 formulation exhibited greater HCA precursor 
formation than the NCL2 and NCL4-derived pellets. Moreover, the NCL4 borate-based 
samples showed the highest biodegradation rate; with silicate-derived structures displaying 
the lowest weight loss after SBF immersion. The results of this study suggested that glass 
composition has significant influence on apatite-forming ability and also degradation rate, 
indicating the possibility to customise the properties of this class of materials towards the 
bone repair and regeneration process.  
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1. Introduction 
Since the first proposed glass (currently known as Bioglass®) developed by Hench in 1969, 
and intended for bone tissue applications [1, 2], bioactive glasses become a class of 
biomaterials which are still widely investigated [3]. 
Among inorganic biomaterials, Bioglass
®
 has received great attention for its ability to form 
a strong bond with soft as well as hard host tissue, resulting in what has been recognised as 
bioactive behaviour [4]. The concept of bioactivity was introduced by Hench at the 
beginning of 70’s, when he described the bonding of 45S5 bioglass to bone as a process 
based on the formation of a carbonated hydroxyapatite (HCA) layer on the surface of the 
material in contact with the host tissue [2]. The development of this glass revolutionised the 
definition of biomaterial, moving the perspective from inert to a material that, interacting 
with the human body, is capable to elicit a specific biological response [5]. 
Around a decade later in Japan Kokubo et al. were the first to synthetize a new glass-
ceramic material currently known as apatite-wollastonite [6]. This bioceramic demonstrated 
excellent mechanical properties and an exceptional ability to form a strong chemical bond 
with bone tissue [7, 8]. In 1990, Kokubo described the capacity of a material to develop an 
HA-like layer on its surface, when immersed in a simulated body fluid (SBF) solution, as 
indicative of its bioactivity [9]. The SBF proposed by Kokubo mimics human blood plasma 
in terms of pH and ionic concentration and it is the most applied preliminary in vitro test to 
assess the bioactive potential of biomedical materials [10]. 
Many new bioactive formulations in the silicate, phosphate and borate-based system and 
with variable types of modiﬁers have been designed [11-13]. However, it has been found 
that small variations in the glass main formulation greatly affect material properties such as 
degradation rate and bioactive potential [14-17]. 
For the first time, highly complex bioceramic formulations (belonging to the silicate and 
borate-based glass family), containing different doping agents (i.e. MgO, MnO2, Al2O3, 
CaF2, Fe2O3, ZnO, CuO, Cr2O3) and in diverse weight percentages, were produced via a 
melting-quenching method [19] and demonstrated good potential as biomaterials for bone 
tissue applications. Following the desirable requirement to develop materials with sufﬁcient 
bioactivity and controllable degradation behaviour, the motivation of the present work was 
to evaluate the effect of these novel bioceramic compositions on apatite-forming ability and 
degradation rate upon immersion in simulated body ﬂuid (SBF) solution. The novel 
materials, processed in form of dense sintered pellets (see Figure 1), were investigated in 
terms of crystallinity by X-ray diffraction (XRD) and morphological structure through 
scanning electron microscopy (SEM) before and after 28 days immersion in SBF. 
Furthermore, the chemical composition of the precipitates was assessed by using x-ray 
photoelectron spectroscopy (XPS) and energy dispersive spectroscopy (EDX). In addition, 
measurements of the pH variations, degradation behaviour and ion leaching potential were 
conducted. 
2. Materials and methods 
2.1 Preparation of bioceramic samples and characterisation  
Three novel bioceramic formulations were investigated in this study, together with AW, 
selected as a well characterised comparator material (see Table 1). All the glasses were 
produced and supplied by Glass Technology Service (GTS) Ltd (Sheffield, UK). The glass 
frits as received were processed to compact pellets, following the same procedure described 
in [18]. 
Briefly, bioceramic pellets were prepared by cold pressing raw glass powders in a 
cylindrical stainless steel mould (diameter 10 mm) using an automatic hydraulic press 
(Specac-Atlas™ 8T, Specac Ltd., UK). Subsequently, the pressed pellets, also called green 
bodies, were treated through a sintering process to consolidate their structure. Hence, they 
were placed in a furnace (Carbolite 1200 CWF, Carbolite GmbH, Germany) and sintered in 
accordance to data derived from hot stage microscopy analysis [18], as shown in Table 2. 
Subsequently, XRD analysis was performed on both sintered and un-sintered samples by 
using a PANalytical X'Pert Pro MPD, powered by a Philips PW3040/60 X-ray generator 
fitted with an X'Celerator detector. Diffraction data was acquired by exposing powder 
samples to Cu-Kα X-ray radiation, which was supplied with 40 kV and a current of 40 mA. 
The data were collected over a 2θ range between 5-80º (2θ), with a step size equal to 
0.0334º, a counting time per step of 200 seconds using the scanning X’Celerator detector. 
Phase identification was carried out by means of the PANalytical X'Pert HighScore Plus© 
software, in conjunction with the ICDD Powder Diffraction File 2 Database (2004), ICDD 
Powder Diffraction File 4 - Minerals (2014) and the Crystallography Open Database 
(February 2013; www.crystallography.net). 
2.2 In vitro bioactivity test in simulated body fluid 
In order to assess the bioactive potential of the novel materials, sintered pellets were soaked 
for 1, 3, 7, 14 and 28 days in SBF, which was prepared following Kokubo’s protocol [10]. 
Each sample was immersed in 10ml of acellular SBF then incubated at 37°C. During the 
incubation time, the SBF solution was replaced every two days to avoid ionic depletion in 
the SBF due to the precipitation of inorganic salts on the samples’ surface. 
At the end of each time interval, the samples were removed from SBF, then gently rinsed 
with deionised water (Veolia Water Technologies, UK) and dried at room temperature 
before starting further characterisation. 
2.3 Sample characterisation  
2.3.1 Morphological and compositional analysis  
The structural characteristics and chemical composition of the upper surface of the samples 
were investigated by SEM/EDS (Philips XL30 ESEM FEG, which is fitted with a Rontec 
Quantax system for the EDS analysis). Before the imaging acquisition, the specimens were 
sputtered with a thin layer of gold (approximately 10nm, sputter time 40s at 40mA), and 
afterward analysed. All the images were taken at an operation voltage of 20 kV, and 
working distance between 5 and 10mm. 
Additionally, to quantitatively evaluate the composition of the precipitates, XPS analysis 
was performed using Theta Probe (Thermo Scientific, East Grinstead, UK), with a micro-
focused AlKa X-ray source (1486.6eV), operated with a 400µm spot size (100W power). 
Survey spectra were collected at a pass energy of 200eV, with the spectrometer operated in 
standard (not angle-resolved) lens mode. The results were expressed as the average of three 
points of each sample surface. 
2.3.2 Weight loss, pH variation, and ionic leaching potential 
The pH of the solutions was measured after each time point using a pH meter (Mettler 
Toledo Ltd., UK), which was calibrated with standard solutions (at pH 4 and 7) every time 
before use. Moreover, the sample solubility was quantitatively assessed by measuring the 
weight loss of the immersed pellets after 1, 3, 7, 14 and 28 days of soaking, using an 
analytical balance (Kern ABT220-5DM), according to the following formula: 
            ( )   
       
   
      
where     is the mass of the sample before the immersion and     is the mass of the 
sample after the immersion. All the results were expressed as average ± standard deviation 
(SD). Furthermore, in order to evaluate the ionic release potential of each composition, the 
ion concentration was measured using an inductively coupled plasma optical emission 
spectrometer Specto-Ciros-Vision (Sheffield University, UK), which allows simultaneous 
multi-element analysis following the calibration of the instrument by introduction of 
standards of known concentrations of the elements of interest.  
3. Results and discussion 
3.1 Sintering and crystal structure evolution 
Sintered bioceramic pellets were successfully fabricated following the heating treatment 
reported in Table 2, and based on the results previously derived from HSM analysis [19]. 
Sintering temperatures, which usually range from 30% to 90% of the melting temperature 
[20], have been found to greatly depend on the material compositions [19] and HSM 
revealed a powerful technique to identify the optimal sintering intervals of the novel 
bioceramics. By comparing the XRD patterns of the glass powders with those of the 
sintered bioceramic pellets (see Figure 2) we can observe that: 
 The post sintering XRD pattern for NCL2 silicate-based glass revealed the presence of 
a crystalline phase identified as diopside (ICDD ref. code 01-073-6374). Diopside is a 
Mg-containing compound, which has already been investigated as a biomaterial for 
bone repair in powder and dense bulk ceramic forms [21]. Furthermore, diopside-
derived scaffolds were found to possess good and stable mechanical properties upon 
immersion in physiological solution due to their low degradation rate [22].  
 The XRD analysis confirmed the amorphous nature of NCL4 formulation even after 
sintering. 
 The thermal process did not affect the crystallinity of NCL7 glass-ceramic, which still 
showed a crystalline phase corresponding to pure silver (ICDD ref. code 04-003-1425).  
 The XRD patterns of AW samples revealed the same crystalline phases 
(hydroxylapatite (ICDD ref. code 01-073-1731) complemented with β-wollastonite 
(ICDD ref. code 01-071-0880)) before and after the sintering process, confirming the 
glass-ceramic nature of this formulation [23].  
3.2 Morphological analysis 
The bioactivity of the sintered pellets before and after 7 and 28 days in immersion in SBF 
solution was firstly evaluated through SEM and EDX analysis, whose outcomes are 
reported in Figure 3 and Figure 4.  
Of particular interest is the difference in behaviour of the two silicate based formulations. 
No apatite nucleation was detected for NCL2-based pellets (see Figure 3(a-c)), which after 
28 days in immersion developed a homogeneous rough layer onto the sample surface 
(Figure 3(c)). Globular shaped agglomerates developed on NCL7 specimens (Figure 4(a-
c)), with a consequent increase in the Ca/P ratio from 1.1 at day 7 to 1.4 at day 28 (Figure 
4(a-c)). These precipitates might be considered HCA precursors (octacalcium phosphate), 
and therefore suggest the capability of NCL7 composition to induce bioactivity [24]. 
Furthermore, for this silicate-based glass the nucleation of globular precipitates was 
associated with the formation of micro-cracks (Figure 4(c)). Crack development is usually a 
common morphological feature, part of the dual reaction of formation of a silica-rich film 
and growth of calcium-phosphate HCA layer, which is typical of bioactive materials [1].  
Although the NCL2 and NCL7 formulations have similar SiO2, CaO, and P2O5 content, the 
more complex formulation of NCL2 glass, based on the incorporation of many intermediate 
oxides, might have reduced its in vitro bioactivity, and thus may explain the absence of 
even HA precursors on its surface [25]. Specifically, the presence of Fe2O3 and MgO with 
respect to other bioglasses in SiO2 - CaO - P2O5 system, and their higher content in 
comparison to the NCL7 main formulation, could have affected the morphology of the 
precipitates and the NCL2 bioactive process [26, 27]. 
Globular and flake shaped agglomerates, rich in calcium and phosphorous, were identified 
on the NCL4 borate-based pellet surface, which increased after 28 days of soaking, as 
demonstrated by the Ca/P ratio that moved from 0.76 at day 7 (Figure 3(d)) to 1.08 at day 
28 (Figure 3(f)) leading to the formation of dicalcium phosphate precipitates [24]. Globular 
agglomerates have been previously observed for less complex borate-based compositions 
after immersion in SBF [28]; however, for more complex NCL4 composition, the presence 
of oxides such as MoO3 and SeO2 might have delayed the formation of the precipitates. 
The extensively documented bioactive properties of AW glass-ceramic [29] were further 
proved in this study. After 7 days in immersion, AW sintered pellets were already 
completely covered by an HCA layer, which at day 28 reached a Ca/P ratio (Figure 4(f)) 
nearly equal to the stoichiometric hydroxyapatite (Ca/P=1.67). It is interesting to observe 
that although the Ca/P ratio of NCL7 precipitates was lower than AW after 28 days in SBF 
immersion, conversely the crack formation process was more pronounced on the NCL7 
than the AW-derived pellets. As suggested by previous studies [1, 13, 30], this behaviour is 
considered the initial stage of the formation of the HCA layer on glass and glass-ceramic 
surface, and hence can be considered a promising feature towards the bioactive potential of 
NCL7 formulation. 
In this study a quantitative elemental characterisation of the sample surfaces before and 
after soaking in SBF was assessed by XPS analysis, in order to estimate the atomic 
concentration of the main elements (Si, Ca and P) involved during the bioactivity process 
[5]. The XPS results (see Figure 5) evidenced that the atomic concentration of calcium and 
phosphorous on the surface of NCL4, NCL7 and AW sintered pellets increased already 
after 24 hours in immersion, reaching values higher than silicon and above 40% after 28 
days of soaking. It is interesting to note that conversely to AW-based samples (Figure 5(d)), 
the level of calcium on the surface of NCL4 and NCL7-based pellets (Figure 5(b-c)) was 
lower than phosphorous for the entire time interval. This behaviour might, therefore, 
suggest the presence of HA precursor (as indicated by the EDX analysis), and hence the 
slower bioactive process for both NCL4 and NCL7 compositions.  
Regarding NCL2-based pellets (see Figure 5(a)), after immersion in SBF solution only the 
calcium level increased, whereas phosphorous remained almost steady (~9.5 after 28 days 
in immersion). The lower diffusion of phosphorous from the outermost surface of NCL2-
based pellets, in comparison to the other formulations, confirmed the lack of bioactivity of 
this composition. 
3.3 pH variation, weight loss and ionic release potential 
Usually glass-based structures are known to dissolve in aqueous solutions with a variable 
rate depending on the kind of network former and its percentage in the glass structure [31].  
For the fabricated pellets, the in vitro degradation behaviour was assessed by measuring 
pellet weight loss after SBF immersion (see Figure 6). NCL2 silicate-based structures 
showed the lowest degradation rate all over the considered interval. The negligible weight 
loss of this class of samples is consistent with the low degradation rate shown by its 
diopside crystalline phase upon immersion in physiological fluids [22]. NCL7 and AW 
specimens showed a similar trend upon SBF immersion, reaching a mass loss around 12% 
and 14% respectively, after 28 days of soaking. 
Considering the NCL4 samples, at the beginning small variations were observed; then from 
3 to 28 days a greater weight loss was measured. These findings confirmed that borate-
based glasses have a faster dissolution rate [32-35]. 
On the other hand, the degradation process of a bioactive glass takes place by ionic 
exchange of soluble ions, which, depending on the glass composition, influence the pH of 
the surrounding media [36]. In order to evaluate the hydrolytical stability of the bioceramic 
pellets after immersion in SBF, the pH changes during the 28 days of immersion were 
assessed.  
Figure 7 shows the pH variation as function of the soaking time resulting from the 
solubility/ionic exchange reactions at the solid/liquid interface [37], during the 28 days of 
immersion in SBF. It can be observed that all the compositions were characterised by a low 
pH variation over the period, which ranged between 7.44 and 7.74. According to the 
mechanism proposed by Hench, the pH of the solution rises very fast initially, followed by 
marginal change in pH with respect to time [5]. In the present case, the almost stable pH 
values might be governed by the total sum of both basic and acidic ion concentration 
present in the main composition [27]. pH values around 7 are usually considered optimal in 
provision of future in vitro cell culture [38].  
In addition, the ionic leaching potential of the sintered pellets soaked in SBF solution was 
assessed by measuring the amount of Si, Ca, and P released into the media after each time 
interval. According to the ICP analysis data (see Figure 8), the highest release of 
phosphorous occurred for AW composition (Figure 8(d)), which further proved the 
bioactivity of this materials [29]. By comparing the silicon leaching profiles for NCL2, 
NCL4 and NCL7 sintered pellets (Figure 8(a-b-c)), it is interesting to observe that the 
presence of boron in the glass structure greatly enhanced the release of this ion. In fact, 
after 3 days in immersion the concentration of silicon released from NCL4-based pellets 
reached a value more than 3 times higher with respect to the silicon released from NCL2 
and NCL7-based samples. These findings confirm that borate-based glasses have a highly 
reactive nature [31, 35, 40], and once in solution they can contribute to the dissolution of 
the other elements present in the glass network.  
4. Conclusion 
Three highly complex glass compositions, NCL2, NCL7 (SiO2-based) and NCL4 (B2O3-
based) were sintered in form of dense pellets, following the data derived from HSM 
analysis. The XRD investigation showed the glass-ceramic nature of NCL2, NCL7 and AW 
compositions after sintering, whilst the NCL4 formulation remained completely 
amorphous. The sensitivity of the novel materials on apatite forming ability and 
biodegradation behaviour was assessed by XRD, SEM, EDS, XPS, ICP and pH variation 
during 28 days of immersion in SBF. The experimental results have indicated that two 
similar silicate glass formulations (NCL2 and NCL7) showed markedly different responses 
in terms of apatite forming ability, microstructure of the precipitates, and dissolution in 
SBF. The less complex of the two glass formulations, NCL7, exhibited the greatest 
bioactive potential, while NCL2 showed no apatite precipitates after 28 days in SBF 
immersion. Furthermore, NCL4 displayed the highest degradation rate, confirming the 
highly reactive nature of borate-based glass compositions.  
In conclusion, the complexity of glass formulations affects significantly in vitro bioactivity 
and degradation behaviour of these materials, as very small variations in glass formulations, 
(even less than 2 wt%), can change completely their bioactivity and solubility. The 
combined effect of ions released in aqueous solutions (such as SBF) can enhance or inhibit 
dissolution and precipitation rates of these materials.   
Acknowledgements 
This work was partly funded by the Arthritis Research UK Tissue Engineering Centre 
(19429); the EC Framework VII RESTORATION (280575) project; and the EPSRC Centre 
for Innovative Manufacture in Medical Devices (EP/K029592). The authors would like to 
thank the NEXUS National EPSRC Service for supporting the XPS analysis. The 
SEM/EDX studies were performed in the School of Chemical Engineering at Newcastle 
University with the support of its staff, and this is gratefully acknowledged. 
 
References 
1. Hench, L.L., Bioceramics: From Concept to Clinic. Journal of the American Ceramic 
Society, 1991. 74(7): p. 1487-1510. 
2. Hench, L.L., Bioactive materials: the potential for tissue regeneration. J Biomed Mater Res, 
1998. 41(4): p. 511-8. 
3. Jones, J.R., Review of bioactive glass: from Hench to hybrids. Acta Biomater, 2013. 9(1): 
p. 4457-86. 
4. Hench, L.L., et al., Bonding mechanisms at the interface of ceramic prosthetic materials. J 
Biomed Mater Res, 1971. 2: p. 117 - 141. 
5. Hench, L.L., Bioceramics. J Am Ceram Soc, 1998. 81: p. 1705 - 1728. 
6. Kokubo, T., et al., KURENAI: Kyoto University Research Information Repository. Bull. 
Inst. Chem. Res., Kyoto Univ, 1982. 60(3-4). 
7. Kokubo, T., A/W glass-ceramic: processing and properties. An introduction to bioceramics, 
1999: p. 75 - 88. 
8. Kokubo, T., Bioceramics and their Clinical Applications. Bioceramics and their Clinical 
Applications. 2008. 1-760. 
9. Kokubo, T., Surface chemistry of bioactive glass-ceramics. Journal of Non-Crystalline 
Solids, 1990. 120(1-3): p. 138-151. 
10. Kokubo, T. and H. Takadama, How useful is SBF in predicting in vivo bone bioactivity? 
Biomaterials, 2006. 27(15): p. 2907-2915. 
11. Jones, J. and A. Clare, Bio-glasses: an introduction. 2012: John Wiley & Sons. 
12. Fu, Q., et al., Silicate, borosilicate, and borate bioactive glass scaffolds with controllable 
degradation rate for bone tissue engineering applications. II. In vitro and in vivo biological 
evaluation. J Biomed Mater Res A, 2010. 95A: p. 172 - 179. 
13. Rahaman, M.N., et al., Bioactive glass in tissue engineering. Acta Biomater, 2011. 7(6): p. 
2355-73. 
14. Abou Neel, E.A., et al., Structure and properties of strontium-doped phosphate-based 
glasses. Journal of the Royal Society Interface, 2009. 6(34): p. 435-446. 
15. Miola, M., et al., In vitro study of manganese-doped bioactive glasses for bone 
regeneration. Materials Science and Engineering C, 2014. 38: p. 107-18. 
16. Novajra, G., et al., Effects of TiO 2-containing phosphate glasses on solubility and in vitro 
biocompatibility. Journal of Biomedical Materials Research - Part A, 2011. 99 A(2): p. 295-
306. 
17. Murphy, S., et al., The effect of composition on ion release from Ca-Sr-Na-Zn-Si glass 
bone grafts. Journal of Materials Science: Materials in Medicine, 2009. 20(11): p. 2207-
2214. 
18. Mancuso, E., et al., Three-dimensional printing of porous load-bearing bioceramic 
scaffolds. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of 
Engineering in Medicine. 0(0): p. 0954411916682984. 
19. Mancuso, E., Processing and characterisation of novel bioceramics for load bearing 
applications, in School of Mechanical and Systems Engineering. PhD thesis 2016, 
Newcastle University. 
20. Aguilar-Reyes, E.A., et al., Processing and in vitro bioactivity of high-strength 45S5 glass-
ceramic scaffolds for bone regeneration. Ceramics International, 2017. 43(9): p. 6868-6875. 
21. Nonami, T. and S. Tsutsumi, Study of diopside ceramics for biomaterials. Journal of 
Materials Science: Materials in Medicine, 1999. 10(8): p. 475-479. 
22. Wu, C., Y. Ramaswamy, and H. Zreiqat, Porous diopside (CaMgSi2O6) scaffold: A 
promising bioactive material for bone tissue engineering. Acta Biomaterialia, 2010. 6(6): p. 
2237-2245. 
23. Xiao, K., et al., Indirect selective laser sintering of apatite-wollostonite glass-ceramic. 
Proceeding Institution of Mechanical Engineering part H, 2008. 222(7): p. 1107-14. 
24. Dorozhkin, S.V., Calcium Orthophosphates as Bioceramics: State of the Art. Journal of 
Functional Biomaterials, 2010. 1(1): p. 22-107. 
25. Groh, D., F. Döhler, and D.S. Brauer, Bioactive glasses with improved processing. Part 1. 
Thermal properties, ion release and apatite formation. Acta Biomaterialia, 2014. 10(10): p. 
4465-4473. 
26. Zhang, Y., et al., The effect of iron incorporation on the in vitro bioactivity and drug release 
of mesoporous bioactive glasses. Ceramics International, 2013. 39(6): p. 6591-6598. 
27. Jha, P. and K. Singh, Effect of MgO on bioactivity, hardness, structural and optical 
properties of SiO2–K2O–CaO–MgO glasses. Ceramics International, 2016. 42(1, Part A): 
p. 436-444. 
28. Fu, Q., et al., Silicate, borosilicate, and borate bioactive glass scaffolds with controllable 
degradation rate for bone tissue engineering applications. I. Preparation and in vitro 
degradation. Journal of Biomedical Materials Research - Part A, 2010. 95(1): p. 164-71. 
29. Magallanes-Perdomo, M., et al., Bone-like forming ability of apatite-wollastonite glass 
ceramic. Journal of the European Ceramic Society, 2011. 31(9): p. 1549-1561. 
30. Dietrich, E., et al., In vitro bioactivity of melt-derived glass 46S6 doped with magnesium. 
Journal of Biomedical Materials Research Part A, 2009. 88A(4): p. 1087-1096. 
31. Fu, Q., et al., Silicate, borosilicate, and borate bioactive glass scaffolds with controllable 
degradation rate for bone tissue engineering applications. II. In vitro and in vivo biological 
evaluation. Journal of Biomedical Materials Research Part A, 2010. 95(1): p. 172-179. 
32. Wang, H., et al., Evaluation of borate bioactive glass scaffolds as a controlled delivery 
system for copper ions in stimulating osteogenesis and angiogenesis in bone healing. 
Journal of Materials Chemistry B, 2014. 2(48): p. 8547-8557. 
33. Deliormanli, A.M., Size-dependent degradation and bioactivity of borate bioactive glass. 
Ceramics International, 2013. 39(7): p. 8087-8095. 
34. Liu, X., et al., Bioactive borate glass scaffolds: in vitro and in vivo evaluation for use as a 
drug delivery system in the treatment of bone infection. Journal of Materials Science: 
Materials in Medicine, 2010. 21(2): p. 575-82. 
35. Yao, A., et al., In vitro bioactive characteristics of borate-based glasses with controllable 
degradation behavior. Journal of the American Ceramic Society, 2007. 90(1): p. 303-306. 
36. Rahaman, M.N., et al., Bioactive glass in tissue engineering. Acta Biomaterialia, 2011. 
7(6): p. 2355-73. 
37. Hoppe, A., N.S. Guldal, and A.R. Boccaccini, A review of the biological response to ionic 
dissolution products from bioactive glasses and glass-ceramics. Biomaterials, 2011. 32: p. 
2757 - 2774. 
38. El-Ghannam, A., P. Ducheyne, and I.M. Shapiro, Formation of surface reaction products on 
bioactive glass and their effects on the expression of the osteoblastic phenotype and the 
deposition of mineralized extracellular matrix. Biomaterials, 1997. 18(4): p. 295-303. 
39. Vitale-Brovarone, C., et al., Biocompatible glass-ceramic materials for bone substitution. 
Journal of Materials Science: Materials in Medicine, 2008. 19(1): p. 471-478. 
40. Huang, W., et al., Kinetics and mechanisms of the conversion of silicate (45S5), borate, and 
borosilicate glasses to hydroxyapatite in dilute phosphate solutions. Journal of Materials 
Science: Materials in Medicine, 2006. 17(7): p. 583-596. 
 
 
Figure 1: Preparation and characterisation of novel sintered bioceramic pellets. 
Figure 2: XRD patterns of: a) NCL2, b) NCL4, c) NCL7 and d) AW before sintering (nS) and 
after sintering (S). ● diopside,  silver,  hydroxylapatite,and   β-wollastonite. 
Figure 3: On the left, morphological (5Kx mag) and compositional analysis (at%) of NCL2 
bioceramic pellet: a) before immersion in SBF, b) after 7 days and c) after 28 days of 
immersion in SBF, with the inset showing the precipitate morphology (10Kx). On the right, 
morphological (5Kx mag) and compositional analysis (at%) of NCL7 bioceramic pellet: d) 
before immersion in SBF, e) after 7 days and f) after 28 days of immersion in SBF, with the 
inset showing the precipitate morphology (10Kx). 
Figure 4: On the left, morphological (5Kx mag) and compositional analysis (at%) of NCL7 
bioceramic pellet: a) before immersion in SBF, b) after 7 days and c) after 28 days of 
immersion in SBF, with the inset showing the precipitate morphology (10Kx). On the right, 
morphological (5Kx mag) and compositional analysis (at%) of AW bioceramic pellet: d) 
before immersion in SBF, e) after 7 days and f) after 28 days of immersion in SBF, with the 
inset showing the precipitate morphology (10Kx). The red arrows indicate the micro-cracks 
formation on the pellet surface. 
Figure 5: Atomic concentration of Si, Ca and P on the upper surface of a) NCL2, b) NCL4, c) 
NCL7 and d) AW bioceramic pellets after immersion in SBF solution up to 28 days. 
Figure 6: Averaged weight loss (±SD) of NCL2, NCL4, NCL7 and AW pellets after soaking in 
SBF solution up to 28 days. 
Figure 7: Averaged pH value (±SD) of SBF solution for NCL2, NCL4, NCL7 and AW 
samples. 
Figure 8: Release profiles of Si, Ca and P ions from a)NCL2, b)NCL4, c) NCL7 and d)AW 
bioceramic pellets immersed in SBF solution. 
Table 1: Composition of the novel glass formulations. 
CODE GLASS COMPOSITION (wt %) 
NCL2 
36.90SiO2 – 9.70P2O5 – 1.90B2O3 – 3.39Na2O – 11.48CaO – 
3.85K2O – 4.41MgO – 2.38MnO2 – 6.97Al2O3 – 2.13CaF2 – 
10.92Fe2O3 – 0.41Li2O – 1.97MoO3 – 1.52SeO2 – 2.07Cr2O3 
NCL4 
16.28SiO2 – 9.63P2O5 – 37.77B2O3 – 4.21Na2O – 3.80CaO – 
6.38K2O – 2.73MgO – 5.52ZnO – 7.03SrO – 2.12CaF2 – 
1.08CuO – 1.95MoO3 – 1.51SeO2  
NCL7 
39.96SiO2 – 9.46P2O5 – 12.39Na2O – 11.19CaO – 2.50K2O – 
1.61MgO – 15.44AgO – 2.13TiO2 – 4.26Fe2O3 – 1.06CuO 
AW 4.6 MgO – 44.7 – CaO – 34 SiO2 – 16.2 P2O5 – 0.5 CaF2 
 
Table 2: Heat treatments for dense pellets. 
CODE SINTERING TREATMENT 
NCL2 10˚/min up to 700˚C, hold for 1 hour 
NCL4 10˚/min up to 625˚C, hold for 1 hour 
NCL7 10˚/min up to 625˚C, hold for 1 hour 
AW 10˚/min up to 850˚C, hold for 1 hour 
 
 Figure 1: Schematic process of novel sintered bioceramic pellets preparation and 
characterisation. 
 
 
Figure 2: XRD patterns of: a) NCL2, b) NCL4, c) NCL7 and d) AW before sintering (nS) and 
after sintering (S). ● diopside,  silver,  hydroxylapatite,and   β-wollastonite. 
 
 Figure 3: On the left, morphological (5Kx mag) and compositional analysis (at%) of NCL2 
bioceramic pellet: a) before immersion in SBF, b) after 7 days and c) after 28 days of 
immersion in SBF, with the inset showing the precipitate morphology (10Kx). On the right, 
morphological (5Kx mag) and compositional analysis (at%) of NCL7 bioceramic pellet: d) 
before immersion in SBF, e) after 7 days and f) after 28 days of immersion in SBF, with the 
inset showing the precipitate morphology (10Kx). 
 
 Figure 4: On the left, morphological (5Kx mag) and compositional analysis (at%) of NCL7 
bioceramic pellet: a) before immersion in SBF, b) after 7 days and c) after 28 days of 
immersion in SBF, with the inset showing the precipitate morphology (10Kx). On the right, 
morphological (5Kx mag) and compositional analysis (at%) of AW bioceramic pellet: d) 
before immersion in SBF, e) after 7 days and f) after 28 days of immersion in SBF, with the 
inset showing the precipitate morphology (10Kx). The red arrows indicate the micro-cracks 
formation on the pellet surface. 
 
 Figure 5: Atomic concentration of Si, Ca and P on the upper surface of a) NCL2, b) NCL4, c) 
NCL7 and d) AW bioceramic pellets after immersion in SBF solution up to 28 days. 
 
Figure 6: Averaged weight loss (±SD) of NCL2, NCL4, NCL7 and AW pellets after soaking in 
SBF solution up to 28 days. 
  
  
Figure 7: Averaged pH value (±SD) of SBF solution for NCL2, NCL4, NCL7 and AW 
samples. 
 
Figure 8: Release profiles of Si, Ca and P ions from a)NCL2, b)NCL4, c) NCL7 and d)AW 
bioceramic pellets immersed in SBF solution. 
 
 
